Literature DB >> 30363404

Lack of Accurate Self-appraisal is Equally Likely in MCI from Parkinson's Disease and Alzheimer's Disease.

Jagan A Pillai1,2, Aaron Bonner-Jackson1,2, Darlene Floden3,2, Hubert Fernandez3,2, James B Leverenz1,2.   

Abstract

BACKGROUND: How accurate are mild cognitive impairment (MCI) patients in assessing their cognitive and functional deficit is often unclear to the clinician. The accuracy of patient self-appraisal in Parkinson's disease-MCI (PD-MCI) has received less attention than amnestic MCI (a-MCI) often associated with Alzheimer's disease. We evaluated if PD-MCI patients demonstrate accurate self-appraisal of their cognitive deficits compared to patients with amnestic a-MCI or non-amnestic MCI (na-MCI).
METHODS: This cross-sectional cohort study included, 30 PD-MCI, 33 a-MCI, and 17 na-MCI patients. Self-appraisal was assessed by comparing responses of caregivers and patients on a validated self-rating questionnaire of cognitive and functional impairments. All patients completed a full neuropsychological evaluation and depression screening measure. Univariate ANOVA, regression, and correlational analyses were employed to identify group differences in self-appraisal scores and relationships between cognitive and functional impairment, depression measures, and self-appraisal scores.
RESULTS: Self-appraisal scores for PD-MCI did not differ significantly from a-MCI and na-MCI. In the PD-MCI group, higher depression scores were associated with lower self-appraisal scores (i.e, patients assessed cognition as worse than caregivers). In a stepwise regression model with self-appraisal scores as the dependent variable, only the depression score was significant predictor among PD-MCI and accounted for 50% of the variance.
CONCLUSIONS: Our findings suggest that impaired patient self-appraisal is equally likely to occur in PD-MCI as in a-MCI and na-MCI patients. Among PD-MCI, depression was the strongest predictor of impaired patient self-appraisal. Impaired insight into cognitive impairment and depression should be considered in both care and research with PD patients.

Entities:  

Keywords:  Alzheimer's disease; Parkinson's disease; anosognosia; mild cognitive impairment; self‐appraisal

Year:  2018        PMID: 30363404      PMCID: PMC6174380          DOI: 10.1002/mdc3.12606

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  28 in total

1.  Functional deficits in patients with mild cognitive impairment: prediction of AD.

Authors:  M H Tabert; S M Albert; L Borukhova-Milov; Y Camacho; G Pelton; X Liu; Y Stern; D P Devanand
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

2.  Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.

Authors:  S E Starkstein; L Sabe; G Petracca; E Chemerinski; G Kuzis; M Merello; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

3.  Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease.

Authors:  A Michon; B Deweer; B Pillon; Y Agid; B Dubois
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154

Review 4.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

5.  Anosognosia in mild cognitive impairment and mild Alzheimer's disease: frequency and neuropsychological correlates.

Authors:  Maria Donata Orfei; Ambra Erika Varsi; Carlo Blundo; Elisabetta Celia; Anna Rosa Casini; Carlo Caltagirone; Gianfranco Spalletta
Journal:  Am J Geriatr Psychiatry       Date:  2010-12       Impact factor: 4.105

6.  Awareness of deficits in mild cognitive impairment and Alzheimer's disease: do MCI patients have impaired insight?

Authors:  Asmus Vogel; Jette Stokholm; Anders Gade; Birgitte Bo Andersen; Anne-Mette Hejl; Gunhild Waldemar
Journal:  Dement Geriatr Cogn Disord       Date:  2004-01-20       Impact factor: 2.959

Review 7.  Depression and Parkinson's disease: current knowledge.

Authors:  Laura Marsh
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

8.  Anosognosia in Alzheimer's disease: a study of associated factors.

Authors:  R Migliorelli; A Tesón; L Sabe; G Petracca; M Petracchi; R Leiguarda; S E Starkstein
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1995       Impact factor: 2.198

Review 9.  Parkinsonian patients and poor awareness of dyskinesias.

Authors:  Sara Pietracupa; Anna Latorre; Alfredo Berardelli; Giovanni Fabbrini
Journal:  Front Neurol       Date:  2014-03-20       Impact factor: 4.003

10.  Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life.

Authors:  Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; Tien K Khoo; David P Breen; Roger A Barker; Daniel Collerton; John-Paul Taylor; David J Burn
Journal:  Parkinsonism Relat Disord       Date:  2014-07-18       Impact factor: 4.891

View more
  3 in total

1.  Improving Self-Awareness of Motor Symptoms in Patients With Parkinson's Disease by Using Mindfulness - A Study Protocol for a Randomized Controlled Trial.

Authors:  Timo Marcel Buchwitz; Franziska Maier; Andrea Greuel; Carsten Eggers
Journal:  Front Psychol       Date:  2020-04-17

2.  Participant and Study Partner Reported Impact of Cognition on Functional Activities in Parkinson's Disease.

Authors:  Brenna Cholerton; Kathleen L Poston; Lu Tian; Joseph F Quinn; Kathryn A Chung; Amie L Hiller; Shu-Ching Hu; Krista Specketer; Thomas J Montine; Karen L Edwards; Cyrus P Zabetian
Journal:  Mov Disord Clin Pract       Date:  2019-12-14

3.  Virtual Reality Functional Capacity Assessment Tool (VRFCAT-SL) in Parkinson's Disease.

Authors:  Travis H Turner; Alexandra Atkins; Richard S E Keefe
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.